Protective effect of empagliflozin against paracetamol-induced acute kidney injury through modulation of AMPK/SIRT1/PGC-1α pathway in experimental mice
- 9 May 2025
- journal article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 500, 117382
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Empagliflozin repurposing in Parkinson’s disease; modulation of oxidative stress, neuroinflammation, AMPK/SIRT-1/PGC-1α, and wnt/β-catenin pathwaysInflammopharmacology, 2023
- An AMP Kinase-pathway dependent integrated stress response regulates ageing and longevityBiogerontology, 2023
- The protective effect of carvacrol on acetaminophen-induced renal damage in male ratsMolecular Biology Reports, 2022
- Empagliflozin suppresses inflammation and protects against acute septic renal injuryInflammopharmacology, 2020
- Empagliflozin alleviates neuronal apoptosis induced by cerebral ischemia/reperfusion injury through HIF-1α/VEGF signaling pathwayArchives of Pharmacal Research, 2020
- Role of Silent Information Regulator 1 (SIRT1) in Regulating Oxidative Stress and InflammationInflammation, 2020
- Empagliflozin, SGLT2 inhibitor, attenuates renal fibrosis in rats exposed to unilateral ureteric obstruction: potential role of klotho expressionNaunyn-Schmiedeberg's Archives of Pharmacology, 2018
- Metabolism and Disposition of Acetaminophen: Recent Advances in Relation to Hepatotoxicity and DiagnosisPharmaceutical Research, 2013
- Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK–SIRT1–PGC1α axis in db/db miceDiabetologia, 2012
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009